Beijing Luzhu Biotechnology Co., Ltd. (HKG:2480)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
24.30
-0.10 (-0.41%)
At close: Mar 6, 2026
Market Cap4.83B +2.1%
Revenue (ttm)n/a
Net Income-148.88M
EPS-0.74
Shares Out198.91M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume200
Average Volume3,230
Open24.30
Previous Close24.40
Day's Range24.30 - 24.30
52-Week Range20.00 - 28.00
Beta-1.32
RSI52.92
Earnings DateMar 18, 2026

About HKG:2480

Beijing Luzhu Biotechnology Co., Ltd., a biotechnology company, focuses on the research and development, production, and sale of human vaccines and therapeutic biologics to prevent and control infectious diseases, and treat cancer and autoimmune diseases in Mainland China. Its clinical-stage product candidates include LZ901, a recombinant herpes zoster vaccine, which completed Phase III clinical trial; K3, a recombinant human anti-tumor necrosis factor-alpha monoclonal antibody injection product for the treatment of various autoimmune diseases,... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2001
Employees 197
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 2480
Full Company Profile

Financial Performance

Financial numbers in CNY Financial Statements